Ignite Creation Date:
2024-05-05 @ 11:37 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00092833
Status:
TERMINATED
Last Update Posted:
2022-02-18
First Post:
2004-09-23
Brief Title:
Investigational Drug in Patients With Hypercholesterolemia or in Patients With Sitosterolemia 0653-026COMPLETED
Sponsor:
Organon and Co
Organization:
Organon and Co
Study Overview
Official Title:
An Open-Label Worldwide Treatment Use Study to Provide Ezetimibe 10 MgDay to Patients With Homozygous Familial Hypercholesterolemia or Homozygous Sitosterolemia
Status:
TERMINATED
Status Verified Date:
2022-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to provide an investigational drug to patients with a specific type of hypercholesterolemia high cholesterol or sitosterolemia unusually high absorption of non-cholesterol sterols in a treatment use setting
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2004_034 | None | None | None |